Epstein Secrets

(7/30, 3.28M), The Washington Examiner <https://www.washingtonexaminer.corn/news/full-dc-appeals-court-agrees-to-rehear-michael-flynn-case> (7/30, Chaitin, 448K), The New York Post <https://nypost.corn/2020/07/30/dc-appeals-court-revives-case-against- michael-flynn/> (7/30, Nelson, 4.57M), Business Insi

rts to develop "an antibody for covid-19. `We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and others

ing on the move are CBS News (7/30, Hymes, 3.68M), ABC News (7/30, Mallin, 2.97M), BBC World News (UK) (7/30, 3.28M), The Washington Examiner (7/30, Chaitin, 448K), The New York Post (7/30, Nelson, 4.57M), Business Insider (7/30, Sheth, Samuelsohn, 3.67M), and Law360 (7/30, Subscription Publication, 8K)

to develop "an antibody for covid-19. ... 'We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and other

ting on the move are CBS News (7/30, Hymes, 3.68M), ABC News (7/30, Mallin, 2.97M), BBC World News wig (7/30, 3.28M), The Washington Examiner (7/30, Chaitin, 448K), The New York Post (7/30, Nelson, 4.57M), Business Insider (7/30, Sheth, Samuelsohn, 3.67M), and Law360 (7/30, Subscription Publication, 8K)

to develop "an antibody for covid-19. ... 'We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and other